The GO results showed that possible miR-221-3p targets may be crucially related to pancreatic cancer growth by exerting effects on diverse cellular biological processes, such as regulation of lipid kinase activity; for MF, the target genes were significantly enriched in the function of insulin receptor binding. The gene discussed is INSR; the disease is pancreatic neoplasm.